This finding supports our hypothesis that non-neuronal cells, PBMCs, from patients with HSP-SPAST show the disease-associated effect of reduced acetylated α-tubulin, similar to previous findings in patient-derived neuronal cells (Abrahamsen et al., 2013; Wali et al., 2020). This evidence concerns the gene SPAST and hereditary spastic paraplegia.